Adjusted EBITDA for fiscal Q4 2025 (period ended Dec. 31, 2025) -- $94.8 million, down from $97.8 million in fiscal Q4 2024, ...
aFPAR (Analog of Fully Processed Active Recombinant): Descriptor for synthetic or recombinant versions of biologic active ...
Consolidated revenue grew 12%, supported by meaningful gross margin expansion and stronger double-digit growth in adjusted EBITDA and operating cash flow. That momentum continued through the fourth ...
Q4 2025 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsSoham Bhonsle - Head of Investor RelationsRobert Reffkin ...
Virginia Gov. Abigail Spanberger delivered Democrats' official response to President Trump's State of the Union address while Sen. Alex Padilla of California gave the Spanish language reply.
As AI citations surge and YouTube takes the lead, brands confront a new marketing race to shape what machines say first ...
Aspen Aerogels, Inc. (NYSE:ASPN) Q4 2025 Earnings Call Transcript February 25, 2026 Aspen Aerogels, Inc. misses on earnings expectations. Reported EPS is $-0.88206 EPS, expectations were $-0.27.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2025 Earnings Call Transcript February 24, 2026 Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $0.07974 EPS, expectations were $0.24.
A lot of the surveillance technology that's coming for us in North America is framed as ‘battle tested’ in Palestine.” ...
New AI capabilities drive smarter automation, enriched metadata, and assisted workflow design for live and file-based ...
Howard Hughes Holdings Inc. (NYSE:HHH) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and thank you for standing by. Welcome to the Howard Hughes Holdings Inc. Fourth Quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results